Episode 234: Amar Kishan, MD, on Neoadjuvant or Adjuvant Radiotherapy for Prostate Cancer
Release Date:
In the first part of our Hollywood tour, Amar Kishan, MD,
joins us to discuss his recent meta-analysis published in the Journal of
Clinical Oncology on the effects of concurrent adjuvant sequencing versus
neoadjuvant concurrent sequencing. Dr. Kishan also gives an overview of the
added benefit that androgen deprivation therapy provides when combined with
radiation therapy. Dr. Kishan is the Vice Chair of Clinical and Translational
Research and Chief of GU Radiotherapy at the University of California, Los
Angeles.
Episode 234: Amar Kishan, MD, on Neoadjuvant or Adjuvant Radiotherapy for Prostate Cancer